Connection
Peter Gottlieb to Europe
This is a "connection" page, showing publications Peter Gottlieb has written about Europe.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.027 |
|
|
|
-
Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P. Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes. Diabetes Care. 2014 Oct; 37(10):2746-54.
Score: 0.027